Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Obesity drugs: huge study highlights new health risks
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
The Health Risks and Benefits of Weight-Loss Drugs
Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
Landmark Study Reveals New Benefits and Risks of Obesity Drugs Like Ozempic
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss.
Ozempic: Landmark study unveils risk and benefits of popular obesity drug
Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an end after a new landmark study.According to Global News, a new observational study published in the journal
New Weight Loss Drugs May Fight Obesity-Related Cancer, Too
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
Weight-loss drugs linked to unexpected benefits and risks
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.
Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and more
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes. View on euronews
Can weight loss drugs curb alcohol addictions? New research looks at the possibility.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs.
14h
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
22h
Are we nearing peak obesity as weight loss drugs gain popularity?
As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...
STAT
12d
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
For years now, companies behind
weight
loss
drugs
like Wegovy and Zepbound have been trying to convince the medical community and the public that
obesity
is a disease and
medications
are the ...
10h
on MSN
Weight-loss treatment for children with obesity has lasting effects, finds study
When children with obesity undergo weight-loss treatment, the results have effects later in life, and the risk of serious ...
9h
on MSN
Weight loss and the changing landscape of medical solutions | Real Men Wear Gowns
Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback